The Trp53 gene is altered in all 5 subtypes, and Kras mutations are present in suppressive myeloid and stromal cells, whereas Ctnnb1 mutations, another driver gene found in 16% of liver cancer cases, are associated primarily with immune exclusion and immune intermediates9,24. This evidence concerns the gene TP53 and liver cancer.